Metraipolis › archive › dc_c5ce35487397

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review — Europe PMC PMID:41782872

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41782872
DOI
10.3389/fimmu.2026.1766847
License (as archived)
solo-consultazione
Archived
2026-11-05T17:14:56.901Z
SHA-256 of the archived text
749065497e7647d98e10e34d835bb11fd04aaa25870224c834465a6b978fbcde
Stable URL of this page
https://metraipolis.com/documento/dc_c5ce35487397

How to cite

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review — Europe PMC PMID:41782872 — Europe PMC (en), https://europepmc.org/article/MED/41782872 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c5ce35487397 (Metraipolis archive dc_c5ce35487397, sha256 749065497e7647d98e10e34d835bb11fd04aaa25870224c834465a6b978fbcde)
BibTeX
@misc{dcc5ce35487397,
  title = {Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review — Europe PMC PMID:41782872},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41782872},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c5ce35487397; sha256 749065497e7647d98e10e34d835bb11fd04aaa25870224c834465a6b978fbcde},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41782872. Agents can read the archived copy with the MCP tool read_document.